Predicting progression of in situ carcinoma in the era of precision genomics
dc.contributor.author | Cheng, Monica | |
dc.contributor.author | Hanna, Nasser H. | |
dc.contributor.author | Davidson, Darrell D. | |
dc.contributor.author | Gunderman, Richard B. | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | en_US |
dc.date.accessioned | 2019-10-17T19:34:08Z | |
dc.date.available | 2019-10-17T19:34:08Z | |
dc.date.issued | 2019-06 | |
dc.identifier.citation | Cheng, M., Hanna, N. H., Davidson, D. D., & Gunderman, R. B. (2019). Predicting progression of in situ carcinoma in the era of precision genomics. Journal of thoracic disease, 11(6), 2222–2225. doi:10.21037/jtd.2019.05.57 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/21188 | |
dc.language.iso | en_US | en_US |
dc.publisher | AME Publishing Company | en_US |
dc.relation.isversionof | 10.21037/jtd.2019.05.57 | en_US |
dc.relation.journal | Journal of Thoracic Disease | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Cancer control | en_US |
dc.subject | Early detection | en_US |
dc.subject | Papanicolaou test | en_US |
dc.subject | Lung cancer | en_US |
dc.subject | Squamous cell carcinoma | en_US |
dc.title | Predicting progression of in situ carcinoma in the era of precision genomics | en_US |
dc.type | Article | en_US |
ul.alternative.fulltext | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626772/ | en_US |